Studies showed that one month after the booster of mRNA-1273.214, participants who had previously received a vaccine and a 50 micrograms booster dose had a significantly higher neutralizing antibody ...
GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat: San Carlos, California Monday, O ...